TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
2.34B
Market cap2.34B
Price-Earnings ratio
15.57
Price-Earnings ratio15.57
Dividend yield
Dividend yield
Average volume
2.21M
Average volume2.21M
High today
$73.10
High today$73.10
Low today
$67.69
Low today$67.69
Open price
$72.49
Open price$72.49
Volume
2.70M
Volume2.70M
52 Week high
$156.00
52 Week high$156.00
52 Week low
$67.69
52 Week low$67.69

Stock Snapshot

The current TransMedics Group(TMDX) stock price is $68.30, with a market capitalization of 2.34B. The stock trades at a price-to-earnings (P/E) ratio of 15.57.

As of 2026-05-10, TransMedics Group(TMDX) stock has fluctuated between $67.69 and $73.10. The current price stands at $68.30, placing the stock +0.9% above today's low and -6.6% off the high.

TransMedics Group(TMDX) shares are trading with a volume of 2.7M, against a daily average of 2.21M.

During the past year, TransMedics Group(TMDX) stock moved between $67.69 at its lowest and $156.00 at its peak.

During the past year, TransMedics Group(TMDX) stock moved between $67.69 at its lowest and $156.00 at its peak.

TMDX News

Simply Wall St 1d
Does TransMedics Revenue Growth And OCS Adoption Clarify Or Complicate Its Profitability Path?

In early May 2026, TransMedics Group reported first-quarter revenue of US$173.93 million, up from US$143.54 million a year earlier, while net income decreased t...

Does TransMedics Revenue Growth And OCS Adoption Clarify Or Complicate Its Profitability Path?
Nasdaq 3d
My Top 3 Stocks to Buy in May

Key Points TransMedics Group's steep sell-off presents an excellent buying opportunity. Rhythm Pharmaceuticals has multiple potential catalysts ahead. Enbrid...

My Top 3 Stocks to Buy in May
Nasdaq 4d
TransMedics Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

TransMedics Q1 2026 Earnings Transcript

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

More TMDX News

Nasdaq 5d
TransMedics Group Profit Drops In Q1

(RTTNews) - TransMedics Group (TMDX) revealed earnings for first quarter that Drops, from the same period last year The company's bottom line totaled $7.32 mil...

TransMedics Group Profit Drops In Q1
Simply Wall St 5d
Assessing TransMedics Group Valuation After European Logistics Expansion And Product Updates

TransMedics Group (TMDX) has drawn fresh attention after agreeing to invest in Germany based PAD Aviation to build a dedicated organ transplant logistics networ...

Assessing TransMedics Group Valuation After European Logistics Expansion And Product Updates

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.